ZBTB20
protein-codingzinc finger and BTB domain containing 20, the group of Zinc fingers C2H2-type|MicroRNA protein coding host genes|BTB domain containing
Gene summary
This gene, which was initially designated as dendritic cell-derived BTB/POZ zinc finger (DPZF), belongs to a family of transcription factors with an N-terminal BTB/POZ domain and a C-terminal DNA-bindng zinc finger domain. The BTB/POZ domain is a hydrophobic region of approximately 120 aa which mediates association with other BTB/POZ domain-containing proteins. This gene acts as a transcriptional repressor and plays a role in many processes including neurogenesis, glucose homeostasis, and postnatal growth. Mutations in this gene have been associated with Primrose syndrome as well as the 3q13.31 microdeletion syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2017]
- ZNF288
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~832.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0009798
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0009798
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0009798
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0009798
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0009798
Submitter: ClinGen
Variants in *ZBTB20* zinc finger regions were first reported in individuals with autosomal dominant Primrose syndrome in 2014 (Cordeddu et al., PMID: 25017102). Phenotypes commonly reported with *ZBTB20* variants include macrocephaly, hypotonia, developmental delay, intellectual disability with expressive speech delay, behavioral issues, facial dysmorphic features, calcification of the external ear cartilage, sparse body hair, skeletal anomalies, distal muscle wasting, contractures, decreased bone mineral density, hearing loss, ocular anomalies, cryptorchidism, findings on brain imaging and altered glucose metabolism (PMID: 33956417). Both missense and putative loss of function variants in *ZBTB20* have been reported in individuals with overlapping features; additionally, *ZBTB20* is the main candidate gene for the 3q13.31 microdeletion syndrome, which also shares clinical features with Primrose syndrome. Individuals with deletions and putative loss of function variants appear to have milder manifestations, while individuals with missense variants appear to be more severely affected. Evidence suggests that the more severe missense variants are acting via a dominant negative effect. Because the phenotypes of individuals with loss of function and dominant negative variants overlap and appear to be part of the same clinical spectrum, the ClinGen ID/Autism GCEP is curating all of this information together under the disease term Primrose syndrome. Seventeen variants (missense, in-frame deletion, frameshift), reported in seventeen probands in five publications (PMIDs: 25017102, 32266967, 30637921, 29737001, 32266967) are included in this curation. The variant p.Met625Val is recurrent and has been reported two times in the published literature (PMIDs: 31321892, 32266967). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. This gene-disease relationship is also supported by experimental evidence. In summary, there is definitive evidence to support the relationship between *ZBTB20* and Primrose syndrome. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on April 18th, 2023 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0009798
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0005015
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dermatologic; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZBTB20 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001348800.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 123 | 3 | 127 | ||
| missense | 29 | 35 | 183 | 45 | 12 | 304 |
| nonsense | 3 | 4 | 5 | 1 | 13 | |
| start loss | 0 | |||||
| frameshift | 10 | 9 | 4 | 23 | ||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 2 | 5 | ||
| Total | 43 | 50 | 195 | 169 | 15 | 472 |
Highest pathogenic variant AF is 0.000010533843
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001335729.1 | 4 | MANE Select | |
| Ensembl | ENSP00000501561.1 | 4 | MANE Select | |
| RefSeq | NP_001157814.1 | 4 | Standard | |
| RefSeq | NP_001157815.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- positive regulation of interferon-beta production
- positive regulation of interleukin-6 production
- positive regulation of tumor necrosis factor production
- positive regulation of glycolytic process
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- transcription regulatory region DNA binding
- metal ion binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- nuclear body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000474710
- Coding exons
- 4
- Length
- 809178
- Individuals with no LoFs
- 125743
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 3
- Defined
- 125746
- p
- 0.0000119
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.27 | 217 | 481 | 0.452 | 0.0000335 | 4859 |
| Missense (PolyPhen) | 67 | 241.18 | 0.27781 | 2262 | ||
| Synonymous | 1.12 | 201 | 222 | 0.904 | 0.0000183 | 1493 |
| Loss of Function | 4.02 | 3 | 24.4 | 0.123 | 0.00000115 | 268 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.0000095 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be a transcription factor that may be involved in hematopoiesis, oncogenesis, and immune responses (PubMed:11352661). Plays a role in postnatal myogenesis, may be involved in the regulation of satellite cells self-renewal (By similarity). {ECO:0000250|UniProtKB:Q8K0L9, ECO:0000269|PubMed:11352661}.;
- Disease
- DISEASE: Primrose syndrome (PRIMS) [MIM:259050]: A disease characterized by macrocephaly, intellectual disability, disturbed behavior, dysmorphic facial features, ectopic calcifications, large calcified ear auricles, and progressive muscle wasting. {ECO:0000269|PubMed:25017102}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.151
Intolerance Scores
- RVIS EVS
- 0.35
- RVIS percentile EVS
- 74.49
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.998
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |